7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Acromegaly D000172 6 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Actinomycosis D000196 2 associated lipids
Addison Disease D000224 3 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Albuminuria D000419 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Angina, Unstable D000789 14 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Honma M et al. RANKL subcellular trafficking and regulatory mechanisms in osteocytes. 2013 J. Bone Miner. Res. pmid:23529793
Vinholt PJ et al. An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma. 2013 Thromb. Res. pmid:23531238
Shang M et al. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. 2013 Clin. Biochem. pmid:23531404
Janda K et al. Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. 2013 Pol. Arch. Med. Wewn. pmid:23535831
Zhan X et al. Storage media enhance osteoclastogenic potential of human periodontal ligament cells via RANKL-independent signaling. 2013 Dent Traumatol pmid:22487464
Tripuwabhrut P et al. Effect of compressive force on human osteoblast-like cells and bone remodelling: an in vitro study. 2013 Arch. Oral Biol. pmid:23583016
Scholtysek C et al. PPARβ/δ governs Wnt signaling and bone turnover. 2013 Nat. Med. pmid:23542786
Stuss M et al. Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. 2013 J. Clin. Endocrinol. Metab. pmid:23543663
Winther S et al. Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease. 2013 Clin. Nephrol. pmid:23547804
Peng X et al. Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. 2013 PLoS ONE pmid:23516466
Umesan UK et al. Assessing salivary biomarkers for analyzing orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23561400
Saini V et al. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. 2013 J. Biol. Chem. pmid:23729679
Wan S Editorial comment: The end of all our exploring ... 2013 Eur J Cardiothorac Surg pmid:23729753
Recht M et al. The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. 2013 Haemophilia pmid:23731369
Wu X et al. Screening of osteoprotegerin-related feature genes in osteoporosis and functional analysis with DNA microarray. 2013 Eur. J. Med. Res. pmid:23731710
Araújo AA et al. Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. 2013 Naunyn Schmiedebergs Arch. Pharmacol. pmid:23775504
Løgstrup BB et al. Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction. 2013 Coron. Artery Dis. pmid:23777975
Zhang Y et al. Expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on osteoclasts and its potential role in rheumatoid arthritis. 2013 Clinics (Sao Paulo) pmid:23778340
Rozas Moreno P et al. Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males? 2013 J. Endocrinol. Invest. pmid:22391059
Liu M et al. Semen Astragali Complanati- and Rhizoma Cibotii-enhanced bone formation in osteoporosis rats. 2013 BMC Complement Altern Med pmid:23782721
Shen Q et al. Curculigoside promotes osteogenic differentiation of bone marrow stromal cells from ovariectomized rats. 2013 J. Pharm. Pharmacol. pmid:23738728
Takeuchi S et al. Acidosis inhibits mineralization in human osteoblasts. 2013 Calcif. Tissue Int. pmid:23754489
Kim SD et al. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. 2013 Biochem. Pharmacol. pmid:23928189
Crosley LK et al. The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. 2013 Mol Nutr Food Res pmid:23934705
Zhang J et al. Feeding blueberry diets to young rats dose-dependently inhibits bone resorption through suppression of RANKL in stromal cells. 2013 PLoS ONE pmid:23936431
Pichler K et al. Towards a better understanding of bone bridge formation in the growth plate - an immunohistochemical approach. 2013 Connect. Tissue Res. pmid:23941205
Bezerra JP et al. Effects of estrogen deficiency and/or caffeine intake on alveolar bone loss, density, and healing: a study in rats. 2013 J. Periodontol. pmid:22873654
Liao C and Hua Y Effect of hydrogen sulphide on the expression of osteoprotegerin and receptor activator of NF-κB ligand in human periodontal ligament cells induced by tension-force stimulation. 2013 Arch. Oral Biol. pmid:24200305
Fontes JD et al. Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study. 2013 Atherosclerosis pmid:23489346
Oliver JL et al. Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas. 2013 Pigment Cell Melanoma Res pmid:23490134
Mankoč Ramuš S et al. SNP rs2073618 of the osteoprotegerin gene is associated with diabetic retinopathy in Slovenian patients with type 2 diabetes. 2013 Biomed Res Int pmid:24228244
Maïmoun L et al. Peripubertal female athletes in high-impact sports show improved bone mass acquisition and bone geometry. 2013 Metab. Clin. Exp. pmid:23490587
Callegari A et al. Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:23990207
Kress DC Invited commentary. 2013 Ann. Thorac. Surg. pmid:23992687
Mozzanega B et al. Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle. 2013 J. Bone Miner. Metab. pmid:23479185
de Matos FR et al. Immunohistochemical detection of receptor activator nuclear κB ligand and osteoprotegerin in odontogenic cysts and tumors. 2013 J. Oral Maxillofac. Surg. pmid:23992784
Yano S et al. Static and dynamic hypergravity responses of osteoblasts and osteoclasts in medaka scales. 2013 Zool. Sci. pmid:23480382
Yabumoto T et al. Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice. 2013 Am J Orthod Dentofacial Orthop pmid:23992809
Ghaffari S et al. The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography. 2013 Cardiol J pmid:23788300
Steagall WK et al. Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. 2013 Am. J. Pathol. pmid:23867796
Anastasilakis AD et al. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. 2013 J. Clin. Endocrinol. Metab. pmid:23788684
Wei CC et al. Total glucosides of paeony prevents juxta-articular bone loss in experimental arthritis. 2013 BMC Complement Altern Med pmid:23870279
Welldon KJ et al. Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. 2013 Mol. Cell. Endocrinol. pmid:23791847
Cao H et al. Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery. 2013 Ann. Thorac. Surg. pmid:23870696
Xu F et al. Adipocytes regulate the bone marrow microenvironment in a mouse model of obesity. 2013 Mol Med Rep pmid:23835909
Dahl JS et al. Relation of osteoprotegerin in severe aortic valve stenosis to postoperative outcome and left ventricular function. 2013 Am. J. Cardiol. pmid:23871267
Zhu J et al. The influence of g.19124G>a genetic polymorphism in the OPG gene on bone mineral density in Chinese women. 2013 Genet Test Mol Biomarkers pmid:23837846
Salbach-Hirsch J et al. The promotion of osteoclastogenesis by sulfated hyaluronan through interference with osteoprotegerin and receptor activator of NF-κB ligand/osteoprotegerin complex formation. 2013 Biomaterials pmid:23871544
Zhou S et al. Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. 2013 PLoS ONE pmid:23874840
Araújo AA et al. Effect of telmisartan on levels of IL-1, TNF-α, down-regulated COX-2, MMP-2, MMP-9 and RANKL/RANK in an experimental periodontitis model. 2013 J. Clin. Periodontol. pmid:24118063
Meneghini M et al. Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation. 2013 Transplantation pmid:23812001
Zhong Z et al. Comparison of the biological response of osteoblasts after tension and compression. 2013 Eur J Orthod pmid:21402736
Suliburska J et al. The association of insulin resistance with serum osteoprotegerin in obese adolescents. 2013 J. Physiol. Biochem. pmid:23695991
Di Bartolo BA et al. TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL. 2013 PLoS ONE pmid:24040204
Kato R et al. Gap-junction-mediated communication in human periodontal ligament cells. 2013 J. Dent. Res. pmid:23677649
Weng CH et al. [Effects of shangke jiegu tablet on the gene expressions of osteoprotegerin and osteoprotegerin ligand in the repairing process of mandibular defect rabbits]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:23596799
Palumbo S and Li WJ Osteoprotegerin enhances osteogenesis of human mesenchymal stem cells. 2013 Tissue Eng Part A pmid:23597005
Zong ming W et al. Bone formation in rabbit cancellous bone explant culture model is enhanced by mechanical load. 2013 Biomed Eng Online pmid:23597232
LaCroix AZ et al. OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational Study. 2013 Bone pmid:23735608
Napimoga MH et al. Low doses of 15d-PGJ2 induce osteoblast activity in a PPAR-gamma independent manner. 2013 Int. Immunopharmacol. pmid:23597428
Bradaschia-Correa V et al. Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats. 2013 Cell Tissue Res. pmid:23636419
Chandran V et al. Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis. 2013 J. Rheumatol. pmid:23637322
Kaludjerovic J and Ward WE Adequate but not supplemental folic acid combined with soy isoflavones during early life improves bone health at adulthood in male mice. 2013 J. Nutr. Biochem. pmid:23643520
Feng X et al. Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β -induced RANKL, OPG, TNF α , and IL-6 expression in human rheumatoid synoviocyte MH7A. 2013 Clin. Dev. Immunol. pmid:24348674
de Moraes M et al. Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts. 2013 J. Oral Pathol. Med. pmid:23278112
Peris P et al. Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. 2013 Mayo Clin. Proc. pmid:23228561
Liu CG et al. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:24517065
Zhang W et al. IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. 2013 Inflammation pmid:22945280
Wang Q et al. [Effects of treadmill exercise on mRNA expression levels of osteoprotegerin, RANKL and RUNX2 in bone tissues of ovariectomized]. 2013 Zhongguo Gu Shang pmid:24605748
Dieckmann M et al. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo. 2013 J. Bone Miner. Res. pmid:22991192
Owen S et al. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. 2013 Anticancer Res. pmid:23267146
Lazzerini PE et al. Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 2013 Joint Bone Spine pmid:22999910
Matsuo K [Osteoimmunologic regulation of aging]. 2013 Clin Calcium pmid:23268303
Ming LG et al. The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro. 2013 Endocrinology pmid:23389955
Piatek S et al. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis. 2013 Maturitas pmid:23391500
Biscetti F et al. Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patients. 2013 Hum. Genet. pmid:22965192
Hemingway F et al. Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT. 2013 Exp. Mol. Pathol. pmid:23391709
Jiang H et al. A randomized controlled trial of pre-conception treatment for periodontal disease to improve periodontal status during pregnancy and birth outcomes. 2013 BMC Pregnancy Childbirth pmid:24321402
Naranjo-Suarez S et al. Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status. 2013 Mol. Cells pmid:23912593
Zhang J et al. Occlusal effects on longitudinal bone alterations of the temporomandibular joint. 2013 J. Dent. Res. pmid:23340211
Feng ZY et al. Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling. 2013 Mol Med Rep pmid:24126801
Yang B et al. Effect of radiation on the Notch signaling pathway in osteoblasts. 2013 Int. J. Mol. Med. pmid:23340672
Wang X et al. Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation. 2013 Chin. J. Traumatol. pmid:24103822
Lotinun S et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. 2013 J. Clin. Invest. pmid:23321671
Chen X et al. Environmental level of cadmium exposure stimulates osteoclasts formation in male rats. 2013 Food Chem. Toxicol. pmid:23954550
Saki F et al. Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation. 2013 J. Bone Miner. Res. pmid:23322328
Srivastava S et al. Role of vanadium (V) in the differentiation of C3H10t1/2 cells towards osteoblast lineage: a comparative analysis with other trace elements. 2013 Biol Trace Elem Res pmid:23325289
Malik P et al. Bone mineral density and bone metabolism in patients with major depressive disorder without somatic comorbidities. 2013 Prog. Neuropsychopharmacol. Biol. Psychiatry pmid:23380173
Pereira GB et al. Acute effects of resistance training on cytokines and osteoprotegerin in women with metabolic syndrome. 2013 Clin Physiol Funct Imaging pmid:23383690
Benslimane-Ahmim Z et al. Mechanistic study of the proangiogenic effect of osteoprotegerin. 2013 Angiogenesis pmid:23386104
Cody JJ et al. Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model. 2013 Lab. Invest. pmid:23358109
Belaya ZE et al. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome. 2013 Osteoporos Int pmid:23358608
Mogelvang R et al. Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP. 2013 Heart pmid:23135978
Grant M et al. Induction of cytokines, MMP9, TIMPs, RANKL and OPG during orthodontic tooth movement. 2013 Eur J Orthod pmid:22987319
Wolf M et al. Potential role of high mobility group box protein 1 and intermittent PTH (1-34) in periodontal tissue repair following orthodontic tooth movement in rats. 2013 Clin Oral Investig pmid:22777389
Wang Y et al. The effect of adenovirus-mediated siRNA targeting BMPR-II on UHMWPE-induced osteoclast formation. 2013 Biomaterials pmid:23079666
Deng YH et al. The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women. 2013 Endocrine pmid:22798246
Sottnik JL and Keller ET Understanding and targeting osteoclastic activity in prostate cancer bone metastases. 2013 Curr. Mol. Med. pmid:23061677
Kerschan-Schindl K Bone turnover in hyperparathyroidism. 2013 Wien Med Wochenschr pmid:22805761
Pereira AC et al. Histomorphometrical and molecular evaluation of endosseous dental implants sites in humans: correlation with clinical and radiographic aspects. 2013 Clin Oral Implants Res pmid:22092653

Table of Content